Evaluation of extraprostatic disease in the staging of prostate cancer by F-18 choline PET/CT-Reference-Cited by-同舟云学术

Evaluation of extraprostatic disease in the staging of prostate cancer by F-18 choline PET/CT

Published:2013-08 Issue:8 Volume:34 Page:733-740
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:

Author:

Calabria Ferdinando,Chiaravalloti Agostino,Tavolozza Mario,Ragano-Caracciolo Cristiana,Schillaci Orazio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference28 articles.

1. .Cancer statistics, 2005.;Jemal;CA Cancer J Clin,2005

2. Pilot comparison of F-fluorocholine and F-fluorodeoxyglucose PETCT with conventional imaging in prostate cancer.;Beauregard;J Med Imaging Radiat Oncol,2010

3. .18FFluorocholine PETCT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients.;Cimitan;Eur J Nucl Med Mol Imaging,2006

4. .Detection of bronchioloalveolar cancer by means of PETCT and 18F-fluorocholine, and comparison with 18F-fluorodeoxyglucose.;Balogova;Nucl Med Commun,2010

5. .PET imaging of hepatocellular carcinoma with 18F-fluoroethylcholine and 11C-choline.;Kolthammer;Eur J Nucl Med Mol Imaging,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiopharmaceuticals;Radiology‐Nuclear Medicine Diagnostic Imaging;2023-03-10

2. Abdomen and pelvis;Atlas of Hybrid Imaging Sectional Anatomy for Pet/ct, PET/MRI and SPECT/CT Vol. 2 : Thorax Abdomen and Pelvis;2023

3. Musculoskeletal system;Atlas of Hybrid Imaging Sectional Anatomy for Pet/ct, PET/MRI and SPECT/CT Vol. 3 : Heart, Lymph Node and Musculoskeletal System;2023

4. Lymph nodes;Atlas of Hybrid Imaging Sectional Anatomy for Pet/ct, PET/MRI and SPECT/CT Vol. 3 : Heart, Lymph Node and Musculoskeletal System;2023

5. TEP/TDM 18F-choline dans les récidives biologiques des cancers de la prostate traites par radiothérapie externe ou curiethérapie : impact du PSA et de sa cinétique;Médecine Nucléaire;2020-01